Green Cross Holdings Corporation

République de Corée


 
Quantité totale PI 50
Rang # Quantité totale PI 27 918
Note d'activité PI 2,2/5.0    19
Rang # Activité PI 43 938
Symbole boursier
ISIN KR7005250006
Capitalisation 696.9B  (KRW)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Publicité; Affaires commerciales

Brevets

Marques

6 11
6 10
6 9
2
 
Dernier brevet 2023 - Viscosity-reducing excipient com...
Premier brevet 2012 - Method for preparing highly conc...
Dernière marque 2025 - GC PLASMALIFE
Première marque 2012 - GREEN CROSS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Wholesale store services featuring human plasma for medical purposes; Retail store services featu...
2024 P/S Drugs for medical purposes; medical diagnostic test strips; medical diagnostic reagents; diagnost...
2023 Invention Viscosity-reducing excipient composition and low-viscosity highly concentrated protein formulatio...
2022 P/S Medicines for human purposes; vaccines; chemical preparations for medicinal purposes; reagents f...
P/S Wholesale distributorships and retail store services featuring pharmaceutical products; Export an...
P/S Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis,...
2019 P/S Nutritional supplements, namely, tonics and alteratives for medical purposes; blood solvent; pha...
P/S Nutritional supplements, namely, tonics and alteratives for medical purposes; pharmaceutical pre...
2018 Invention Method of preparing composition containing factor viii (fviii) and von willebrand factor (vwf) wi...
Invention Method for preparing composition containing factor 8 capable of controlling content of von willeb...
P/S Collection and preservation of human blood; Genetic testing for medical purposes; Medical informa...
P/S Medical screening; medical screening services in the field of screening of blood plasma for medic...
P/S Advertising, namely, advertising flyer distribution, advertising text publication services for ot...
P/S Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardia...
P/S Sensitized paper; graphite for industrial purposes; ceramic glazing; antifreeze; enzymes for use ...
P/S Sensitized paper; chemicals used in industry and microorganisms other than for medical and veter...
P/S Flavorings for beverages [essential oils]; cosmetics; soaps for personal use; oils for perfumes ...
2017 P/S Pharmaceutical agents affecting digestive organs; veterinary substances and preparations; reagen...
P/S Blood plasma-derivatives, namely albumins for use as a therapeutic agent in surgery and blood los...
P/S Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; p...
Invention Method for purifying fibrinogen. rd glycine precipitation); and (d) dissolving the precipitate of...
Invention Method for purifying fibrinogen. The present disclosure relates to a method for purifying f...
Invention Method for purifying fibrinogen. The present invention relates to a method for purifying fibrinog...
2016 P/S Medical screening; Medical screening services in the field of screening of blood plasma for medic...
Invention Methods for preparing hepatitis b immunoglobulin derived from plasma. The present invention relat...
Invention Preparation method of plasma-derived hepatitis b human immunoglobulin agent. The present inventio...
2014 Invention Method for purifying immunoglobulin. The present invention relates to a method for purifying an i...
Invention Method for purifying immunoglobulin. The present invention relates to a method for purifying immu...
2012 P/S Wholesale distributorships featuring pharmaceutical products; retail store services featuring ph...
Invention Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin seal...